Not recruiting
Colorectal cancer metastatic
Not recruitingStudy of Nous-209 Genetic Vaccine and Pembrolizumab for Patients with Advanced Microsatellite Instability-High Colorectal Cancer
Registered drugNo placebo
Study of Nous-209 Genetic Vaccine and Pembrolizumab for Patients with Advanced Microsatellite Instability-High Colorectal Cancer
Registered drugNo placebo
- Disease:Colorectal cancer metastatic
- Substances:GAD20-209-FSP-A1GAD20-209-FSP-A2+7
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:GAD20-209-FSP-A1


